首页 > 最新文献

Journal of Chromatography B最新文献

英文 中文
Development and validation of an LC-MS/MS method for quantifying total and unbound doravirine in human plasma LC-MS/MS定量人血浆中总多拉韦林和未结合多拉韦林方法的建立和验证。
IF 2.8 3区 医学 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2025-02-01 DOI: 10.1016/j.jchromb.2024.124439
Rizqah Bernard, Sydwell P. Maputla, Phiwe Zuma, Anton Joubert, Sandra Castel, Marthinus van der Merwe, Edda Zangenberg, Lubbe Wiesner
A robust LC-MS/MS method was developed to quantify total and unbound doravirine in plasma samples from patients receiving daily doses of 100 mg doravirine, in combination with lamivudine and tenofovir disoproxil fumarate, in a phase 3 clinical trial. The trial is ongoing, and sample analysis is planned to commence once all samples have been collected. The method was validated to quantify both total and unbound doravirine using a single calibration curve. Protein precipitation was used to obtain the total doravirine from plasma and ultrafiltration was used to obtain the unbound doravirine. A Kinetex 1.7 µm EVO C18 100 Å column was used for chromatography using a gradient mobile phase (0.1 % formic acid in water and 0.1 % formic acid acetonitrile) at a flow rate of 250 µL/min during a five minute runtime. The analyte was ionized by positive electrospray ionization and detection was by multiple reaction monitoring on a Sciex API3200 triple quadrupole mass spectrometer. Using calibration standards prepared in whole plasma, the calibration curve fitted a quadratic regression (weighted by 1/x) over a calibration range of 7.00–2000 ng/mL and was applied successfully for the measurement of both total and unbound doravirine. Validation experiments, conducted according to international guidelines, proved the accuracy and precision of the method over three consecutive days. The method demonstrated robustness in the presence of matrix components, different anticoagulants, hemolyzed blood (2 %), and concomitant medications, showing the necessary sensitivity and selectivity for the quantification of both total and unbound doravirine concentrations expected in the study samples.
在一项3期临床试验中,研究人员开发了一种强大的LC-MS/MS方法,用于量化每天服用100 mg多拉韦林、拉米夫定和富马酸替诺福韦二氧吡酯的患者血浆样本中的总多拉韦林和未结合的多拉韦林。试验正在进行中,并计划在收集完所有样本后开始进行样本分析。验证了该方法可以使用单一校准曲线定量总多拉韦林和未结合的多拉韦林。用蛋白沉淀法从血浆中获得总多拉韦林,用超滤法获得未结合的多拉韦林。色谱柱为Kinetex 1.7µm EVO C18 100 Å,采用梯度流动相(0.1%甲酸水溶液和0.1%甲酸乙腈),流速为250µL/min,运行时间为5分钟。分析物用正电喷雾电离,在Sciex API3200三重四极杆质谱仪上进行多重反应监测。采用全血浆中制备的校准标准,校准曲线在7.00-2000 ng/mL的校准范围内符合二次回归(加权1/x),并成功应用于总和未结合的多拉韦林的测量。根据国际准则进行的验证实验连续三天证明了该方法的准确性和精密度。该方法在基质成分、不同抗凝剂、溶血(2%)和伴随药物的存在下表现出稳健性,显示出对研究样本中预期的总浓度和未结合的多拉韦林浓度进行定量的必要敏感性和选择性。
{"title":"Development and validation of an LC-MS/MS method for quantifying total and unbound doravirine in human plasma","authors":"Rizqah Bernard,&nbsp;Sydwell P. Maputla,&nbsp;Phiwe Zuma,&nbsp;Anton Joubert,&nbsp;Sandra Castel,&nbsp;Marthinus van der Merwe,&nbsp;Edda Zangenberg,&nbsp;Lubbe Wiesner","doi":"10.1016/j.jchromb.2024.124439","DOIUrl":"10.1016/j.jchromb.2024.124439","url":null,"abstract":"<div><div>A robust LC-MS/MS method was developed to quantify total and unbound doravirine in plasma samples from patients receiving daily doses of 100 mg doravirine, in combination with lamivudine and tenofovir disoproxil fumarate, in a phase 3 clinical trial. The trial is ongoing, and sample analysis is planned to commence once all samples have been collected. The method was validated to quantify both total and unbound doravirine using a single calibration curve. Protein precipitation was used to obtain the total doravirine from plasma and ultrafiltration was used to obtain the unbound doravirine. A Kinetex 1.7 µm EVO C18 100 Å column was used for chromatography using a gradient mobile phase (0.1 % formic acid in water and 0.1 % formic acid acetonitrile) at a flow rate of 250 µL/min during a five minute runtime. The analyte was ionized by positive electrospray ionization and detection was by multiple reaction monitoring on a Sciex API3200 triple quadrupole mass spectrometer. Using calibration standards prepared in whole plasma, the calibration curve fitted a quadratic regression (weighted by 1/x) over a calibration range of 7.00–2000 ng/mL and was applied successfully for the measurement of both total and unbound doravirine. Validation experiments, conducted according to international guidelines, proved the accuracy and precision of the method over three consecutive days. The method demonstrated robustness in the presence of matrix components, different anticoagulants, hemolyzed blood (2 %), and concomitant medications, showing the necessary sensitivity and selectivity for the quantification of both total and unbound doravirine concentrations expected in the study samples.</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1252 ","pages":"Article 124439"},"PeriodicalIF":2.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142926115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the effect of Ela tablets in the treatment of diabetic nephropathy based on rat experiments and screening strategy for quality markers of Ela tablets targeting aldose reductase 基于大鼠实验的Ela片治疗糖尿病肾病的疗效评价及针对醛糖还原酶的Ela片质量标记物筛选策略
IF 2.8 3区 医学 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2025-02-01 DOI: 10.1016/j.jchromb.2025.124450
Shunan Guo , Aizaiti Keremu , Miao Hu , Fei He , Maitinuer Maiwulanjiang , Haji Akber Aisa , Xuelei Xin
Ela tablets (ALP) is a traditional Uyghur medicinal formulation comprising 9 herbs. Clinical applications have demonstrated its potential in treating diabetic nephropathy (DN). However, its specific medicinal effects and pharmacodynamic components have not been elucidated. This research aims to investigate the efficacy of ALP in treating DN and to explore the quality markers (Q-markers) for its exertion of efficacy. Using the UHPLC-Q-Orbitrap HRMS technique, a total of 60 compounds were identified within ALP. Animal experiments were conducted to investigate the effect of ALP intervention at doses of 80, 160, and 320 mg/kg in Sprague-Dawley rats. Then, fingerprints of ten batches of ALP extracts were established using UPLC-DAD. Spectrum-effect relationship analysis of these fingerprints and aldose reductase (AR) activity was conducted by chemometric analysis methods. The results were further validated by molecular docking and cellular experiments. The animal experiments indicated that ALP had a therapeutic effect on DN. Specifically, ALP reduced biochemical indexes such as serum creatinine (SCr), 24-hour urinary total protein (24 h UTP), uric acid (UA), blood urea nitrogen (BUN), triglycerides (TG), and total cholesterol (TC). ALP stabilized body weight and fasting blood glucose, enhanced the antioxidant capacity of kidneys, and improved renal pathology. Comprehensive analysis indicated that crocin-I and gallic acid may be used as Q-markers for ALP. In summary, ALP has been identified as a treatment for DN, and gallic acid and crocin-I can be used as its Q-markers.
埃拉片(ALP)是维吾尔族传统药材配方,由9种草药组成。临床应用已证明其在治疗糖尿病肾病(DN)方面的潜力。然而,其具体的药理作用和药效学成分尚未阐明。本研究旨在探讨ALP治疗DN的疗效,并探讨其发挥疗效的质量标记(q -marker)。采用UHPLC-Q-Orbitrap HRMS技术,共鉴定出60个化合物。采用动物实验研究80、160、320 mg/kg ALP对Sprague-Dawley大鼠的干预效果。采用UPLC-DAD建立10批ALP提取物的指纹图谱。采用化学计量学方法对指纹图谱与醛糖还原酶(AR)活性进行了光谱效应关系分析。通过分子对接和细胞实验进一步验证了这一结果。动物实验表明ALP对DN有治疗作用。具体来说,ALP降低了血清肌酐(SCr)、24小时尿总蛋白(24 h UTP)、尿酸(UA)、血尿素氮(BUN)、甘油三酯(TG)和总胆固醇(TC)等生化指标。ALP稳定体重和空腹血糖,增强肾脏的抗氧化能力,改善肾脏病理。综合分析表明,藏红花素i和没食子酸可作为ALP的q标记物。综上所述,ALP已被确定为DN的治疗方法,没食子酸和藏红花素i可作为其q标记物。
{"title":"Evaluation of the effect of Ela tablets in the treatment of diabetic nephropathy based on rat experiments and screening strategy for quality markers of Ela tablets targeting aldose reductase","authors":"Shunan Guo ,&nbsp;Aizaiti Keremu ,&nbsp;Miao Hu ,&nbsp;Fei He ,&nbsp;Maitinuer Maiwulanjiang ,&nbsp;Haji Akber Aisa ,&nbsp;Xuelei Xin","doi":"10.1016/j.jchromb.2025.124450","DOIUrl":"10.1016/j.jchromb.2025.124450","url":null,"abstract":"<div><div>Ela tablets (ALP) is a traditional Uyghur medicinal formulation comprising 9 herbs. Clinical applications have demonstrated its potential in treating diabetic nephropathy (DN). However, its specific medicinal effects and pharmacodynamic components have not been elucidated. This research aims to investigate the efficacy of ALP in treating DN and to explore the quality markers (Q-markers) for its exertion of efficacy. Using the UHPLC-Q-Orbitrap HRMS technique, a total of 60 compounds were identified within ALP. Animal experiments were conducted to investigate the effect of ALP intervention at doses of 80, 160, and 320 mg/kg in Sprague-Dawley rats. Then, fingerprints of ten batches of ALP extracts were established using UPLC-DAD. Spectrum-effect relationship analysis of these fingerprints and aldose reductase (AR) activity was conducted by chemometric analysis methods. The results were further validated by molecular docking and cellular experiments. The animal experiments indicated that ALP had a therapeutic effect on DN. Specifically, ALP reduced biochemical indexes such as serum creatinine (SCr), 24-hour urinary total protein (24 h UTP), uric acid (UA), blood urea nitrogen (BUN), triglycerides (TG), and total cholesterol (TC). ALP stabilized body weight and fasting blood glucose, enhanced the antioxidant capacity of kidneys, and improved renal pathology. Comprehensive analysis indicated that crocin-I and gallic acid may be used as Q-markers for ALP. In summary, ALP has been identified as a treatment for DN, and gallic acid and crocin-I can be used as its Q-markers.</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1252 ","pages":"Article 124450"},"PeriodicalIF":2.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142963255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extraction and quantitation of fentanyl in exhaled breath condensate using a magnetic dispersive solid phase based on graphene oxide and covalent organic framework composite and LC-MS/MS analysis 基于氧化石墨烯和共价有机骨架复合材料的磁分散固相萃取和定量呼出液中芬太尼的LC-MS/MS分析。
IF 2.8 3区 医学 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2025-02-01 DOI: 10.1016/j.jchromb.2024.124447
Sedigeh Mohamadzadeh , Ali Akbar Fathi , Abolghasem Jouyban , Afshin Gharekhani , Mohamadbagher Hosseini , Maryam Khoubnasabjafari , Vahid Jouyban-Gharamaleki , Mir Ali Farajzadeh , Mohammad Reza Afshar Mogaddam
Free fentanyl is responsible for its pharmacological effects, but its total concentration is typically determined for therapeutic drug monitoring purposes. Determination of fentanyl concentration can help reduce the prescribed doses, leading to fewer side effects and increased effectiveness. Therefore, predicting free drug concentration in pharmaceutical research is crucial. The aim of this study was to determine free fentanyl in exhaled breath condensate. These samples were extracted using a dispersive micro solid phase extraction method with a new adsorbent made of graphene oxide, magnetic iron oxide nanoparticles, and covalent organic framework. 10 mg of the adsorbent was added to the sample solution adjusted to pH 10. After sonication for 5 min, the sorbent was separated using an external magnet. The adsorbed analyte was then eluted from the sorbent surface using a mixture of acetonitrile, methanol, and deionized water in a ratio of 42.5:42.5:15 (v/v/v) and analyzed using liquid chromatography-tandem mass spectrometry system. The calibration curve showed high linearity in the range of 0.17–10000 μg L−1 with a coefficient of determination of 0.9998 and good repeatability with a relative standard deviation of 4.1 %. Additionally, this method provided a low detection limit of 0.05 μg L−1 and quantification limit of 0.17 μg L−1.
游离芬太尼对其药理作用负责,但其总浓度通常用于治疗药物监测目的。确定芬太尼浓度有助于减少处方剂量,减少副作用,提高疗效。因此,预测游离药物浓度在药物研究中是至关重要的。本研究的目的是测定呼出液中游离芬太尼。采用由氧化石墨烯、磁性氧化铁纳米颗粒和共价有机骨架组成的新型吸附剂,采用分散微固相萃取法提取样品。将吸附剂10 mg加入到调整pH为10的样品溶液中。超声5分钟后,用外磁铁分离吸附剂。然后用乙腈、甲醇和去离子水的混合物以42.5:42.5:15 (v/v/v)的比例从吸附剂表面洗脱被吸附的分析物,使用液相色谱-串联质谱系统进行分析。在0.17 ~ 10000 μg -1范围内线性良好,测定系数为0.9998,重复性好,相对标准偏差为4.1%。该方法低检出限为0.05 μg L-1,定量限为0.17 μg L-1。
{"title":"Extraction and quantitation of fentanyl in exhaled breath condensate using a magnetic dispersive solid phase based on graphene oxide and covalent organic framework composite and LC-MS/MS analysis","authors":"Sedigeh Mohamadzadeh ,&nbsp;Ali Akbar Fathi ,&nbsp;Abolghasem Jouyban ,&nbsp;Afshin Gharekhani ,&nbsp;Mohamadbagher Hosseini ,&nbsp;Maryam Khoubnasabjafari ,&nbsp;Vahid Jouyban-Gharamaleki ,&nbsp;Mir Ali Farajzadeh ,&nbsp;Mohammad Reza Afshar Mogaddam","doi":"10.1016/j.jchromb.2024.124447","DOIUrl":"10.1016/j.jchromb.2024.124447","url":null,"abstract":"<div><div>Free fentanyl is responsible for its pharmacological effects, but its total concentration is typically determined for therapeutic drug monitoring purposes. Determination of fentanyl concentration can help reduce the prescribed doses, leading to fewer side effects and increased effectiveness. Therefore, predicting free drug concentration in pharmaceutical research is crucial. The aim of this study was to determine free fentanyl in exhaled breath condensate. These samples were extracted using a dispersive micro solid phase extraction method with a new adsorbent made of graphene oxide, magnetic iron oxide nanoparticles, and covalent organic framework. 10 mg of the adsorbent was added to the sample solution adjusted to pH 10. After sonication for 5 min, the sorbent was separated using an external magnet. The adsorbed analyte was then eluted from the sorbent surface using a mixture of acetonitrile, methanol, and deionized water in a ratio of 42.5:42.5:15 (v/v/v) and analyzed using liquid chromatography-tandem mass spectrometry system. The calibration curve showed high linearity in the range of 0.17–10000 μg L<sup>−1</sup> with a coefficient of determination of 0.9998 and good repeatability with a relative standard deviation of 4.1 %. Additionally, this method provided a low detection limit of 0.05 μg L<sup>−1</sup> and quantification limit of 0.17 μg L<sup>−1</sup>.</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1252 ","pages":"Article 124447"},"PeriodicalIF":2.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142997757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel LC-MS/MS assay for low concentrations of creatinine in sweat and saliva to validate biosensors for continuous monitoring of renal function 一种新的LC-MS/MS测定汗液和唾液中低浓度肌酐的方法,以验证生物传感器对肾功能的连续监测。
IF 2.8 3区 医学 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2025-02-01 DOI: 10.1016/j.jchromb.2024.124444
Sophie Adelaars , Chyara S.M. Lapré , Patricia Raaijmakers , Constantijn J.A.M. Konings , Massimo Mischi , R. Arthur Bouwman , Daan van de Kerkhof
Monitoring of kidney function traditionally relies on plasma creatinine concentrations, necessitating invasive blood draws. Non-invasively obtainable biofluids, such as sweat and saliva, present a patient-friendly alternative with potential for continuous monitoring. This study focusses on developing and validating a novel Liquid Chromatography- tandem Mass Spectrometry (LC-MS/MS) assay as a reference test for measuring low creatinine concentrations in sweat and saliva. We explore the correlation between these biofluids and plasma creatinine concentrations during haemodialysis to support future biosensor applications. Creatinine concentrations were measured in sweat, saliva, and plasma obtained from forty patients undergoing haemodialysis. A novel LC-MS/MS assay was developed to quantify low creatinine concentrations in sweat and saliva. Correlation analyses were performed to compare the creatinine concentrations across biofluids. The novel LC-MS assay demonstrated high accuracy (93.9–97.8%) and low imprecision (3.4–8%) in measuring very low creatinine concentrations with a limit of quantitation of 1.26 µmol/L. Significant correlations ware found between creatinine concentrations in sweat and saliva with those in plasma (ρ: 0.68 and 0.80, respectively). During haemodialysis, creatinine concentrations decreased concurrently in all three biofluids. The strong correlations observed imply that these non-invasive biofluids could serve as reliable alternatives to traditional blood tests for kidney function assessment. This study enhances our understanding of creatinine excretion pathways of creatinine and provides a foundation for developing innovative, patient-friendly approaches for continuous kidney function monitoring, such as wearable biosensors.
传统的肾功能监测依赖于血浆肌酐浓度,因此需要进行侵入性抽血。无创获取的生物液体,如汗液和唾液,提供了一种对患者友好的替代方案,具有持续监测的潜力。本研究的重点是开发和验证一种新的液相色谱-串联质谱(LC-MS/MS)测定方法,作为测定汗液和唾液中低肌酐浓度的参考测试。我们探索血液透析期间这些生物体液和血浆肌酐浓度之间的相关性,以支持未来生物传感器的应用。测定了40例血液透析患者的汗液、唾液和血浆中的肌酐浓度。建立了一种新的LC-MS/MS测定方法来定量汗液和唾液中的低肌酐浓度。进行相关性分析,比较不同生物体液的肌酐浓度。新型LC-MS法在测量极低的肌酐浓度时具有较高的准确度(93.9-97.8%)和较低的不精确度(3.4-8%),定量限为1.26µmol/L。汗液和唾液中的肌酐浓度与血浆中的肌酐浓度之间存在显著相关性(ρ分别为0.68和0.80)。在血液透析期间,所有三种生物体液中的肌酐浓度同时下降。观察到的强相关性表明,这些非侵入性生物液体可以作为评估肾功能的传统血液检查的可靠替代品。这项研究增强了我们对肌酐排泄途径的理解,并为开发创新的、对患者友好的持续肾功能监测方法(如可穿戴生物传感器)提供了基础。
{"title":"A novel LC-MS/MS assay for low concentrations of creatinine in sweat and saliva to validate biosensors for continuous monitoring of renal function","authors":"Sophie Adelaars ,&nbsp;Chyara S.M. Lapré ,&nbsp;Patricia Raaijmakers ,&nbsp;Constantijn J.A.M. Konings ,&nbsp;Massimo Mischi ,&nbsp;R. Arthur Bouwman ,&nbsp;Daan van de Kerkhof","doi":"10.1016/j.jchromb.2024.124444","DOIUrl":"10.1016/j.jchromb.2024.124444","url":null,"abstract":"<div><div>Monitoring of kidney function traditionally relies on plasma creatinine concentrations, necessitating invasive blood draws. Non-invasively obtainable biofluids, such as sweat and saliva, present a patient-friendly alternative with potential for continuous monitoring. This study focusses on developing and validating a novel Liquid Chromatography- tandem Mass Spectrometry (LC-MS/MS) assay as a reference test for measuring low creatinine concentrations in sweat and saliva. We explore the correlation between these biofluids and plasma creatinine concentrations during haemodialysis to support future biosensor applications. Creatinine concentrations were measured in sweat, saliva, and plasma obtained from forty patients undergoing haemodialysis. A novel LC-MS/MS assay was developed to quantify low creatinine concentrations in sweat and saliva. Correlation analyses were performed to compare the creatinine concentrations across biofluids. The novel LC-MS assay demonstrated high accuracy (93.9–97.8%) and low imprecision (3.4–8%) in measuring very low creatinine concentrations with a limit of quantitation of 1.26 µmol/L. Significant correlations ware found between creatinine concentrations in sweat and saliva with those in plasma (ρ: 0.68 and 0.80, respectively). During haemodialysis, creatinine concentrations decreased concurrently in all three biofluids. The strong correlations observed imply that these non-invasive biofluids could serve as reliable alternatives to traditional blood tests for kidney function assessment. This study enhances our understanding of creatinine excretion pathways of creatinine and provides a foundation for developing innovative, patient-friendly approaches for continuous kidney function monitoring, such as wearable biosensors.</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1252 ","pages":"Article 124444"},"PeriodicalIF":2.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143078301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Green and High Throughput HPTLC Method for Simultaneous Estimation of Celecoxib and Tramadol Hydrochloride in their Newly Approved Analgesic Combination and Spiked Plasma with Dichromic Green and Blue Assessments 绿色和高通量高效液相色谱法同时测定塞来昔布和盐酸曲马多新批准的镇痛药组合及加标血浆中绿、蓝二色评价。
IF 2.8 3区 医学 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2025-02-01 DOI: 10.1016/j.jchromb.2024.124434
Mona M. Abdel Moneim, Mohamed M.A. Hamdy
The FDA “Food and Drug Administration” recently approved a novel co-crystal formulation of Celecoxib (CEX) and Tramadol (TRM) for the treatment of adults suffering from moderate to severe pain in several conditions. This novel combination has advantages over co-administration of the two drugs individually as better patient compliance, synergism and lower therapeutic cost. This work presents the first “High performance Thin Layer Chromatographic” (HPTLC) quantitative analytical technique for CEX and TRM simultaneous assay in bulk, their new dosage form and plasma. The proposed HPTLC assay is based on separation of CEX and TRM on silica gel 60 F254 sheets followed by densitometric scanning at 270 nm. The plates’ development was carried out using a mobile phase of ethyl acetate–methanol–ammonia (5:5:0.05, v/v). The two drugs showed linearity of 0.025–1 μg.band−1 & for plasma analysis linearity range was 0.2–10 μg.mL−1 plasma. The proposed chromatographic technique was validated and showed satisfying validation characteristics of linearity, selectivity, precision and accuracy. In addition, the assay was evaluated by AGREE, AGREEprep, ComplexMoGAPI and BAGI for greenness and blueness to ensure the method’s environmental sustainability and its safety for routine quality control assay of this novel combination.
美国食品和药物管理局(FDA)最近批准了一种新的塞来昔布(CEX)和曲马多(TRM)共晶制剂,用于治疗几种情况下患有中度至重度疼痛的成年人。这种新的组合比单独使用两种药物具有更好的患者依从性,增效性和更低的治疗成本。本文介绍了首个用于CEX和TRM同时批量测定的“高效薄层色谱”(HPTLC)定量分析技术,以及它们的新剂型和血浆。所提出的HPTLC分析方法是在硅胶60f254薄片上分离CEX和TRM,然后在270 nm处进行密度扫描。采用流动相:乙酸乙酯-甲醇-氨(5:5:0.05,v/v)对板进行显影。两药呈0.025-1 μg的线性关系。等离子体分析band-1&线性范围为0.2 ~ 10 μg. ml -1。该方法具有良好的线性、选择性、精密度和准确度。此外,还对该方法进行了AGREE、AGREEprep、ComplexMoGAPI和BAGI的绿度和蓝度评价,以确保该方法的环境可持续性及其在该新组合的常规质量控制分析中的安全性。
{"title":"Green and High Throughput HPTLC Method for Simultaneous Estimation of Celecoxib and Tramadol Hydrochloride in their Newly Approved Analgesic Combination and Spiked Plasma with Dichromic Green and Blue Assessments","authors":"Mona M. Abdel Moneim,&nbsp;Mohamed M.A. Hamdy","doi":"10.1016/j.jchromb.2024.124434","DOIUrl":"10.1016/j.jchromb.2024.124434","url":null,"abstract":"<div><div>The FDA “Food and Drug Administration” recently approved a novel co-crystal formulation of Celecoxib (CEX) and Tramadol (TRM) for the treatment of adults suffering from moderate to severe pain in several conditions. This novel combination has advantages over co-administration of the two drugs individually as better patient compliance, synergism and lower therapeutic cost. This work presents the first “High performance Thin Layer Chromatographic” (HPTLC) quantitative analytical technique for CEX and TRM simultaneous assay in bulk, their new dosage form and plasma.<!--> <!-->The proposed HPTLC assay is based on separation of CEX and TRM on silica gel 60 F254 sheets followed by densitometric scanning at 270 nm. The plates’ development was carried out using a mobile phase of ethyl acetate–methanol–ammonia (5:5:0.05, v/v). The two drugs showed linearity of 0.025–1 μg.band<sup>−1</sup> <!-->&amp; for plasma analysis linearity range was 0.2–10 μg.mL<sup>−1</sup> <!-->plasma. The proposed chromatographic technique was validated and showed satisfying validation characteristics of linearity, selectivity, precision and accuracy. In addition, the assay was evaluated by AGREE, AGREEprep, ComplexMoGAPI and BAGI for greenness and blueness to ensure the method’s environmental sustainability and its safety for routine quality control assay of this novel combination.</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1252 ","pages":"Article 124434"},"PeriodicalIF":2.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142891001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
“On-off” elution mechanism facilitates the rapid LC/MS/MS-based analysis of peptide antibiotics in human plasma “开-关”洗脱机制有助于LC/MS/MS快速分析人血浆中肽类抗生素。
IF 2.8 3区 医学 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2025-02-01 DOI: 10.1016/j.jchromb.2024.124438
Huan Tong , Yong Qiao , Yang Deng, Fang Yuan, Debiao Xiang, Siwei Guo, Bing Xu, Xin Li
Individualized medication with peptide antibiotics, guided by therapeutic drug monitoring, is essential to treat infections caused by multidrug-resistant bacteria. Peptide antibiotics exhibit an “on-off” elution mechanism on a C18 column, leading to adsorption at the column inlet in all-aqueous conditions. Unlike small molecules, column length minimally influences their retention, with longer columns simply broadening peptide antibiotic peaks due to unnecessary post-column volume. Our theory suggests short columns can achieve comparable separation quality and enable faster analysis. Consequently, we developed a rapid LC-MS/MS method using an ultra-short (4 × 2.0 mm) column to quantify five peptide antibiotics in human plasma simultaneously. Calibration curves demonstrated strong linear regression (R2 > 0.996). The inter- and intra-accuracy at the three QC levels ranged from 86.7 % to 109.1 %, and at the LLOQ, it was between 87.6 % and 116.0 %. The precision for QCs and LLOQ was consistently below 11.7 % and 18.5 %, respectively. This method, characterized by simplicity and universality, was undoubtedly useful in clinically tailoring peptide antibiotic medication for individual patients.
在治疗药物监测的指导下,使用多肽抗生素进行个体化治疗,对于治疗多重耐药细菌引起的感染至关重要。多肽抗生素在C18柱上表现出“开-关”的洗脱机制,导致在全水条件下在柱入口吸附。与小分子不同,柱长度对其保留的影响最小,由于不必要的柱后体积,较长的柱只会拓宽肽抗生素峰。我们的理论表明,短柱可以达到相当的分离质量,并使分析更快。因此,我们开发了一种快速LC-MS/MS方法,使用超短(4 × 2.0 mm)柱同时定量人血浆中的五种肽抗生素。校正曲线具有较强的线性回归(R2 > 0.996)。三个质量控制水平间和内准确度为86.7% ~ 109.1%,下限准确度为87.6% ~ 116.0%。质谱和定量限的精密度分别低于11.7%和18.5%。该方法具有简便、通用性强的特点,在临床为个别患者量身定制肽抗生素用药方面无疑是有用的。
{"title":"“On-off” elution mechanism facilitates the rapid LC/MS/MS-based analysis of peptide antibiotics in human plasma","authors":"Huan Tong ,&nbsp;Yong Qiao ,&nbsp;Yang Deng,&nbsp;Fang Yuan,&nbsp;Debiao Xiang,&nbsp;Siwei Guo,&nbsp;Bing Xu,&nbsp;Xin Li","doi":"10.1016/j.jchromb.2024.124438","DOIUrl":"10.1016/j.jchromb.2024.124438","url":null,"abstract":"<div><div>Individualized medication with peptide antibiotics, guided by therapeutic drug monitoring, is essential to treat infections caused by multidrug-resistant bacteria. Peptide antibiotics exhibit an “on-off” elution mechanism on a C18 column, leading to adsorption at the column inlet in all-aqueous conditions. Unlike small molecules, column length minimally influences their retention, with longer columns simply broadening peptide antibiotic peaks due to unnecessary post-column volume. Our theory suggests short columns can achieve comparable separation quality and enable faster analysis. Consequently, we developed a rapid LC-MS/MS method using an ultra-short (4 × 2.0 mm) column to quantify five peptide antibiotics in human plasma simultaneously. Calibration curves demonstrated strong linear regression (R2 &gt; 0.996). The inter- and intra-accuracy at the three QC levels ranged from 86.7 % to 109.1 %, and at the LLOQ, it was between 87.6 % and 116.0 %. The precision for QCs and LLOQ was consistently below 11.7 % and 18.5 %, respectively. This method, characterized by simplicity and universality, was undoubtedly useful in clinically tailoring peptide antibiotic medication for individual patients.</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1252 ","pages":"Article 124438"},"PeriodicalIF":2.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142926110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and validation of a UHPLC-MS/MS method for the quantitative analysis of trans-ISRIB in human plasma 人血浆中反式isrib的UHPLC-MS/MS定量分析方法的建立与验证。
IF 2.8 3区 医学 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2025-02-01 DOI: 10.1016/j.jchromb.2025.124469
Weizhuan He, Akshay Suresh Patil, Yan Xu
The integrated stress response (ISR) is a cellular defense mechanism activated under stress conditions. When the ISR is activated, it slows the production of proteins, the building blocks that cells need to function. Trans-integrated stress response inhibitor (trans-ISRIB) is a compound that can reverse the effects of ISR activation, showing promise for treating neurodegenerative diseases. The preclinical and clinical evaluation of trans-ISRIB necessitates a reliable analytical method. This study presents the development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method for the quantitative analysis of trans-ISRIB in human plasma, conforming to the U.S. FDA’s guidelines for bioanalytical method validation. The method developed utilizes a liquid–liquid extraction procedure to prepare plasma samples with a spiked internal standard (IS). The extracts containing trans-ISRIB and the IS were dried under nitrogen, reconstituted in the mobile phase, and separated on a Waters XSelect HSS T3 column under isocratic conditions with a mobile phase containing 0.1 % acetic acid in 70 % methanol aqueous solution at a flow rate of 0.500 mL/min. Detection and quantification were accomplished using a positive electrospray ionization tandem mass spectrometer (ESI+-MS/MS) operated in multiple-reaction-monitoring (MRM) mode. The method demonstrated a linear calibration range for trans-ISRIB concentrations from 0.500 to 1.00 x 103 nM, with high specificity, precision, accuracy, and recovery. This method addresses a significant analytical gap, offering a robust tool for quantifying trans-ISRIB in human plasma.
Chemical compounds studied in this article: 2-(4-chlorophenoxy)-N-[4-[[2-(4-chlorophenoxy)acetyl]amino]cyclohexyl]acetamide (trans-ISRIB) (CAS # 1597403–47-8); 2-(4-chlorophenoxy)-N-(2-{[(4-chlorophenoxy)acetyl]amino}ethyl)acetamide (CAS # 327071–30-7).
综合应激反应(integrated stress response, ISR)是细胞在应激条件下激活的一种防御机制。当ISR被激活时,它会减慢蛋白质的产生,而蛋白质是细胞运作所需的基本成分。反式综合应激反应抑制剂(trans-ISRIB)是一种可以逆转ISR激活效应的化合物,有望用于治疗神经退行性疾病。trans-ISRIB的临床前和临床评价需要可靠的分析方法。本研究开发并验证了一种用于人血浆中反式isrib定量分析的超高效液相色谱-串联质谱(UHPLC-MS/MS)方法,该方法符合美国FDA的生物分析方法验证指南。该方法采用液-液萃取工艺,用加标内标(IS)制备血浆样品。含trans-ISRIB和IS的提取物在氮气下干燥,在流动相中重组,在Waters XSelect HSS T3柱上等压条件下分离,流动相中含有0.1%醋酸,流速为0.500 mL/min, 70%甲醇水溶液。采用多反应监测(MRM)模式的正电喷雾电离串联质谱仪(ESI+-MS/MS)完成检测和定量。该方法对trans-ISRIB浓度的线性校准范围为0.500 ~ 1.00 × 103 nM,具有较高的特异性、精密度、准确度和回收率。该方法解决了一个重要的分析空白,为定量人血浆中trans-ISRIB提供了一个强大的工具。本文研究的化合物:2-(4-氯苯氧基)- n -[4-[[2-(4-氯苯氧基)乙酰基]氨基]环己基]乙酰胺(trans-ISRIB) (CAS # 1597403-47-8);2-(4-氯苯氧基)- n -(2-{(4-氯苯氧基)乙酰基]氨基}乙基)乙酰胺(CAS # 327071-30-7)。
{"title":"Development and validation of a UHPLC-MS/MS method for the quantitative analysis of trans-ISRIB in human plasma","authors":"Weizhuan He,&nbsp;Akshay Suresh Patil,&nbsp;Yan Xu","doi":"10.1016/j.jchromb.2025.124469","DOIUrl":"10.1016/j.jchromb.2025.124469","url":null,"abstract":"<div><div>The integrated stress response (ISR) is a cellular defense mechanism activated under stress conditions. When the ISR is activated, it slows the production of proteins, the building blocks that cells need to function. <em>Trans</em>-integrated stress response inhibitor (<em>trans</em>-ISRIB) is a compound that can reverse the effects of ISR activation, showing promise for treating neurodegenerative diseases. The preclinical and clinical evaluation of <em>trans</em>-ISRIB necessitates a reliable analytical method. This study presents the development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method for the quantitative analysis of <em>trans</em>-ISRIB in human plasma, conforming to the U.S. FDA’s guidelines for bioanalytical method validation. The method developed utilizes a liquid–liquid extraction procedure to prepare plasma samples with a spiked internal standard (IS). The extracts containing <em>trans</em>-ISRIB and the IS were dried under nitrogen, reconstituted in the mobile phase, and separated on a Waters XSelect HSS T3 column under isocratic conditions with a mobile phase containing 0.1 % acetic acid in 70 % methanol aqueous solution at a flow rate of 0.500 mL/min. Detection and quantification were accomplished using a positive electrospray ionization tandem mass spectrometer (ESI<sup>+</sup>-MS/MS) operated in multiple-reaction-monitoring (MRM) mode. The method demonstrated a linear calibration range for <em>trans</em>-ISRIB concentrations from 0.500 to 1.00 x 10<sup>3</sup> nM, with high specificity, precision, accuracy, and recovery. This method addresses a significant analytical gap, offering a robust tool for quantifying <em>trans</em>-ISRIB in human plasma.</div><div><strong>Chemical compounds studied in this article:</strong> 2-(4-chlorophenoxy)-<em>N</em>-[4-[[2-(4-chlorophenoxy)acetyl]amino]cyclohexyl]acetamide (<em>trans</em>-ISRIB) (CAS # 1597403–47-8); 2-(4-chlorophenoxy)-N-(2-{[(4-chlorophenoxy)acetyl]amino}ethyl)acetamide (CAS # 327071–30-7).</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1252 ","pages":"Article 124469"},"PeriodicalIF":2.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142997689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An integrated approach using molecular docking, network pharmacology, and UPLC-Q-TOF-MS analysis to investigate the chemical makeup and mechanism of Xiaoqinglong decoction against asthma 采用分子对接、网络药理学、UPLC-Q-TOF-MS等综合方法研究小青龙汤抗哮喘的化学成分及作用机制
IF 2.8 3区 医学 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2025-01-31 DOI: 10.1016/j.jchromb.2025.124490
Shuang Wei , Xueting Li , Xinyu Li, Rui Wang, Yuming Wang, Yubo Li
Objective: This study aims to investigate the potential mechanisms by which Xiaoqinglong decoction (XQLD) exerts its therapeutic effects on asthma. This will be achieved through the application of the UPLC-Q-TOF-MS coupling technique, integrated with network pharmacology and molecular docking methodologies. Methods: The UPLC-Q-TOF-MS technique was employed to perform a qualitative analysis of both the aqueous extract of XQLD and the drug-containing serum. The Swiss TargetPrediction, OMIM, and GeneCards databases were utilized to identify blood-derived components and disease-associated targets. Subsequently, a protein-protein interaction (PPI) network was constructed by intersecting these datasets to identify key targets, which were then subjected to Gene Ontology (GO) functional analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. Cytoscape software facilitated the construction of a ‘drug-component-disease-target’ network to enable visualization and analysis, thereby aiding in the prediction of targets and signaling pathways of XQLD in the treatment of asthma. Finally, molecular docking of the pertinent incoming components to the central target was conducted utilizing AutoDock Vina and PyMol software. Results: A comprehensive analysis identified 102 components within the aqueous extract of XQLD, alongside 93 components in the drug-containing serum. Additionally, 90 compound-disease shared targets and 45 key targets were identified through PPI network analysis. Notably, compounds such as apigenin, l-asarinin, 6-shogaol, ellagic acid, kaempferol, and naringenin are pivotal in mediating the therapeutic effects of XQLD in asthma treatment. The primary molecular targets of XQLD for asthma include SRC, AKT1, EGFR, ESR1, HIF1A, and PIK3CA. The results of the molecular docking analysis indicated that the binding energies between the core target and the active ingredient were ≤ −5.5 kcal/mol, demonstrating a strong affinity. Conclusion: This study elucidated the chemical composition, potential targets, and action pathways of the aqueous extract of XQLD and its drug-containing serum. It preliminarily identified the material basis and mechanism of action, thereby providing a foundation for further in-depth research into the mechanisms underlying XQLD and its clinical applications.
目的:探讨小青龙汤治疗哮喘的可能机制。这将通过应用UPLC-Q-TOF-MS耦合技术,结合网络药理学和分子对接方法来实现。方法:采用UPLC-Q-TOF-MS技术对XQLD水提液和含药血清进行定性分析。利用瑞士TargetPrediction、OMIM和GeneCards数据库鉴定血液来源成分和疾病相关靶标。随后,通过交叉这些数据集构建蛋白质-蛋白质相互作用(PPI)网络,确定关键靶点,然后进行基因本体(GO)功能分析和京都基因与基因组百科全书(KEGG)途径富集分析。Cytoscape软件促进了“药物成分-疾病靶点”网络的构建,从而实现可视化和分析,从而帮助预测XQLD治疗哮喘的靶点和信号通路。最后,利用AutoDock Vina和PyMol软件将相关入站组分与中心靶点进行分子对接。结果:经综合分析,XQLD水提物中鉴定出102种成分,含药血清中鉴定出93种成分。此外,通过PPI网络分析确定了90个化合物-疾病共享靶点和45个关键靶点。值得注意的是,芹菜素、l-asarinin、6-shogaol、鞣花酸、山奈酚和柚皮素等化合物在XQLD治疗哮喘的治疗效果中起着关键作用。XQLD治疗哮喘的主要分子靶点包括SRC、AKT1、EGFR、ESR1、HIF1A和PIK3CA。分子对接分析结果表明,核心靶点与活性成分之间的结合能≤−5.5 kcal/mol,具有较强的亲和力。结论:本研究阐明了XQLD水提物及其含药血清的化学成分、潜在靶点和作用途径。初步确定了XQLD的物质基础和作用机制,为进一步深入研究XQLD的作用机制及临床应用奠定了基础。
{"title":"An integrated approach using molecular docking, network pharmacology, and UPLC-Q-TOF-MS analysis to investigate the chemical makeup and mechanism of Xiaoqinglong decoction against asthma","authors":"Shuang Wei ,&nbsp;Xueting Li ,&nbsp;Xinyu Li,&nbsp;Rui Wang,&nbsp;Yuming Wang,&nbsp;Yubo Li","doi":"10.1016/j.jchromb.2025.124490","DOIUrl":"10.1016/j.jchromb.2025.124490","url":null,"abstract":"<div><div>Objective: This study aims to investigate the potential mechanisms by which Xiaoqinglong decoction (XQLD) exerts its therapeutic effects on asthma. This will be achieved through the application of the UPLC-Q-TOF-MS coupling technique, integrated with network pharmacology and molecular docking methodologies. Methods: The UPLC-Q-TOF-MS technique was employed to perform a qualitative analysis of both the aqueous extract of XQLD and the drug-containing serum. The Swiss TargetPrediction, OMIM, and GeneCards databases were utilized to identify blood-derived components and disease-associated targets. Subsequently, a protein-protein interaction (PPI) network was constructed by intersecting these datasets to identify key targets, which were then subjected to Gene Ontology (GO) functional analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. Cytoscape software facilitated the construction of a ‘drug-component-disease-target’ network to enable visualization and analysis, thereby aiding in the prediction of targets and signaling pathways of XQLD in the treatment of asthma. Finally, molecular docking of the pertinent incoming components to the central target was conducted utilizing AutoDock Vina and PyMol software. Results: A comprehensive analysis identified 102 components within the aqueous extract of XQLD, alongside 93 components in the drug-containing serum. Additionally, 90 compound-disease shared targets and 45 key targets were identified through PPI network analysis. Notably, compounds such as apigenin, l-asarinin, 6-shogaol, ellagic acid, kaempferol, and naringenin are pivotal in mediating the therapeutic effects of XQLD in asthma treatment. The primary molecular targets of XQLD for asthma include SRC, AKT1, EGFR, ESR1, HIF1A, and PIK3CA. The results of the molecular docking analysis indicated that the binding energies between the core target and the active ingredient were ≤ −5.5 kcal/mol, demonstrating a strong affinity. Conclusion: This study elucidated the chemical composition, potential targets, and action pathways of the aqueous extract of XQLD and its drug-containing serum. It preliminarily identified the material basis and mechanism of action, thereby providing a foundation for further in-depth research into the mechanisms underlying XQLD and its clinical applications.</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1254 ","pages":"Article 124490"},"PeriodicalIF":2.8,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143372032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Separation of full and empty adeno-associated virus particles using a novel multi-modal anion exchange membrane 利用新型多模态阴离子交换膜分离满和空腺相关病毒颗粒
IF 2.8 3区 医学 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2025-01-31 DOI: 10.1016/j.jchromb.2025.124499
Xiaolei Hao , Ronny Horax , S. Ranil Wickramasinghe , Xianghong Qian
A novel multi-modal anion exchange (MMAEX) membrane with both electrostatic and hydrophobic interaction moieties was developed for the separation of full and empty AAV2 capsids with only slight differences in surface charge and hydrophobicity. Both gradient and two-step elution have been able to separate the full and empty capsids effectively. During gradient elution with slight increase in conductivity coupled with weakening electrostatic and enhanced hydrophobic interactions between the ligand and the capsids, two distinctive elution peaks representing empty and full capsids were resolved. Full capsid recovery of 94 % at 89 % purity has been achieved with a loading density of ∼1012 virus particles per milliliter of membrane volume. During the two-step elution process, the functionalized membrane can achieve 88 % full capsid recovery at 75 % purity, or 67 % recovery at 89 % purity, or 59 % recovery at 93 % purity at first-step conductivity of 7.0, 7.5 and 8.0 mS/cm respectively and a loading density of ∼1013 particles per milliliter of membrane volume. Our results indicate that our MMAEX membrane coupled with careful modulation of capsid-ligand interaction has superior performance for separating the full and empty AAV capsids.
研制了一种具有静电和疏水相互作用的新型多模态阴离子交换(MMAEX)膜,用于分离AAV2满壳和空壳,其表面电荷和疏水性仅存在微小差异。梯度洗脱和两步洗脱都能有效地分离出满壳和空壳。在梯度洗脱过程中,电导率略有增加,加上配体与衣壳之间的静电减弱和疏水相互作用增强,两个不同的洗脱峰分别代表空衣壳和满衣壳。在每毫升膜体积的装载密度为~ 1012个病毒颗粒的情况下,以89%的纯度实现了94%的全衣壳回收率。在两步洗脱过程中,功能化膜在纯度为75%时可实现88%的全衣壳回收率,在纯度为89%时可实现67%的回收率,在纯度为93%时可实现59%的回收率,第一步电导率分别为7.0、7.5和8.0 mS/cm,每毫升膜体积的负载密度为~ 1013个颗粒。我们的研究结果表明,我们的MMAEX膜结合了衣壳-配体相互作用的精心调制,在分离满衣壳和空衣壳方面具有优异的性能。
{"title":"Separation of full and empty adeno-associated virus particles using a novel multi-modal anion exchange membrane","authors":"Xiaolei Hao ,&nbsp;Ronny Horax ,&nbsp;S. Ranil Wickramasinghe ,&nbsp;Xianghong Qian","doi":"10.1016/j.jchromb.2025.124499","DOIUrl":"10.1016/j.jchromb.2025.124499","url":null,"abstract":"<div><div>A novel multi-modal anion exchange (MMAEX) membrane with both electrostatic and hydrophobic interaction moieties was developed for the separation of full and empty AAV2 capsids with only slight differences in surface charge and hydrophobicity. Both gradient and two-step elution have been able to separate the full and empty capsids effectively. During gradient elution with slight increase in conductivity coupled with weakening electrostatic and enhanced hydrophobic interactions between the ligand and the capsids, two distinctive elution peaks representing empty and full capsids were resolved. Full capsid recovery of 94 % at 89 % purity has been achieved with a loading density of ∼10<sup>12</sup> virus particles per milliliter of membrane volume. During the two-step elution process, the functionalized membrane can achieve 88 % full capsid recovery at 75 % purity, or 67 % recovery at 89 % purity, or 59 % recovery at 93 % purity at first-step conductivity of 7.0, 7.5 and 8.0 mS/cm respectively and a loading density of ∼10<sup>13</sup> particles per milliliter of membrane volume. Our results indicate that our MMAEX membrane coupled with careful modulation of capsid-ligand interaction has superior performance for separating the full and empty AAV capsids.</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1255 ","pages":"Article 124499"},"PeriodicalIF":2.8,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143403499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A new indirect method for the quantification of total organic iodine (TOI) in environmental waters by inductively coupled plasma with mass spectrometry and liquid chromatography with tandem mass spectrometry 建立了电感耦合等离子体质谱法和液相色谱串联质谱法间接测定环境水体中总有机碘(TOI)的方法
IF 2.8 3区 医学 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2025-01-30 DOI: 10.1016/j.jchromb.2025.124489
Jinbo Chen , Shinya Echigo , Yuto Tada , Klon D.C. Hinneh , Sadahiko Itoh
The formation of emerging iodinated disinfection by-products (I-DBPs) is associated with iodine sources including organic compounds. Total organic iodine (TOI) was used as a bulk index of organic iodinated compounds because of the difficulty in identifying and quantifying individual organic iodinated compounds in environmental waters. Conventional methods for the direct quantification of TOI require complicated pretreatments, which has promoted many studies to attempt to simplify the quantification of TOI by an indirect measurement. In current indirect methods, TOI is mainly calculated as the differences between the concentration of total iodine (TI) and inorganic iodine (I and IO3-) by liquid chromatography-inductively coupled plasma with mass spectrometry (LC-ICP-MS). However, without accurate identification and discrimination by LC-ICP-MS, possible co-eluting iodinated compounds may be detected as I and IO3-. To measure TOI more accurately, a simple method was developed by ICP-MS and liquid chromatography-tandem mass spectrometry (LC-MSMS). TI was measured by ICP-MS, and the spiked recoveries of tested iodinated compounds showed acceptable accuracy and repeatability in Milli-Q water and environmental waters, respectively. I and IO3- were first simultaneously measured by LC-MSMS without redox pretreatments. The limits of quantification of I and IO3- in this method were 0.05 μg I/L and 0.4 μg/L (0.3 μg I/L), respectively. The method is highly sensitive, and the actual concentration of I and IO3- can be calculated by the spiked recovery. The method was successfully applied by measuring TOI concentration (2.2 to 17 μg I/L) in various types of environmental waters.
新出现的碘化消毒副产物(I-DBPs)的形成与包括有机化合物在内的碘源有关。由于环境水体中单个有机碘化合物难以识别和定量,故采用总有机碘(TOI)作为有机碘化合物的体积指标。传统的TOI直接定量方法需要复杂的预处理,这促使许多研究试图通过间接测量来简化TOI的定量。在目前的间接方法中,TOI主要是通过液相色谱-电感耦合等离子体质谱法(LC-ICP-MS)计算总碘(TI)和无机碘(I−和IO3-)浓度之差。然而,如果没有LC-ICP-MS的准确鉴定和判别,可能的共洗脱碘化化合物可能被检测为I -和IO3-。为了更准确地测量TOI,建立了ICP-MS和液相色谱-串联质谱(LC-MSMS)相结合的简便方法。TI采用ICP-MS测定,所测碘化合物的加标回收率分别在milliq水和环境水中具有可接受的准确性和可重复性。在不进行氧化还原预处理的情况下,采用LC-MSMS同时测定I−和IO3-。该方法的定量限分别为0.05 μg I/L和0.4 μg/L (0.3 μg I/L)。该方法灵敏度高,可通过加峰回收率计算出实际的I−和IO3-浓度。该方法成功应用于不同类型环境水体TOI浓度(2.2 ~ 17 μg I/L)的测定。
{"title":"A new indirect method for the quantification of total organic iodine (TOI) in environmental waters by inductively coupled plasma with mass spectrometry and liquid chromatography with tandem mass spectrometry","authors":"Jinbo Chen ,&nbsp;Shinya Echigo ,&nbsp;Yuto Tada ,&nbsp;Klon D.C. Hinneh ,&nbsp;Sadahiko Itoh","doi":"10.1016/j.jchromb.2025.124489","DOIUrl":"10.1016/j.jchromb.2025.124489","url":null,"abstract":"<div><div>The formation of emerging iodinated disinfection by-products (I-DBPs) is associated with iodine sources including organic compounds. Total organic iodine (TOI) was used as a bulk index of organic iodinated compounds because of the difficulty in identifying and quantifying individual organic iodinated compounds in environmental waters. Conventional methods for the direct quantification of TOI require complicated pretreatments, which has promoted many studies to attempt to simplify the quantification of TOI by an indirect measurement. In current indirect methods, TOI is mainly calculated as the differences between the concentration of total iodine (TI) and inorganic iodine (<span><math><msup><mi>I</mi><mo>−</mo></msup></math></span> and <span><math><msup><msub><mtext>IO</mtext><mn>3</mn></msub><mo>-</mo></msup></math></span>) by liquid chromatography-inductively coupled plasma with mass spectrometry (LC-ICP-MS). However, without accurate identification and discrimination by LC-ICP-MS, possible co-eluting iodinated compounds may be detected as <span><math><msup><mi>I</mi><mo>−</mo></msup></math></span> and <span><math><msup><msub><mtext>IO</mtext><mn>3</mn></msub><mo>-</mo></msup></math></span>. To measure TOI more accurately, a simple method was developed by ICP-MS and liquid chromatography-tandem mass spectrometry (LC-MSMS). TI was measured by ICP-MS, and the spiked recoveries of tested iodinated compounds showed acceptable accuracy and repeatability in Milli-Q water and environmental waters, respectively. <span><math><msup><mi>I</mi><mo>−</mo></msup></math></span> and <span><math><msup><msub><mtext>IO</mtext><mn>3</mn></msub><mo>-</mo></msup></math></span> were first simultaneously measured by LC-MSMS without redox pretreatments. The limits of quantification of <span><math><msup><mi>I</mi><mo>−</mo></msup></math></span> and <span><math><msup><msub><mtext>IO</mtext><mn>3</mn></msub><mo>-</mo></msup></math></span> in this method were 0.05 <span><math><mi>μ</mi></math></span>g I/L and 0.4 <span><math><mi>μ</mi></math></span>g/L (0.3 <span><math><mi>μ</mi></math></span>g I/L), respectively. The method is highly sensitive, and the actual concentration of <span><math><msup><mi>I</mi><mo>−</mo></msup></math></span> and <span><math><msup><msub><mtext>IO</mtext><mn>3</mn></msub><mo>-</mo></msup></math></span> can be calculated by the spiked recovery. The method was successfully applied by measuring TOI concentration (2.2 to 17 <span><math><mi>μ</mi></math></span>g I/L) in various types of environmental waters.</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1254 ","pages":"Article 124489"},"PeriodicalIF":2.8,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143272982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Chromatography B
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1